PureTech Health (PRTC)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

116.20p
   
  • Change Today:
      13.20p
  • 52 Week High: 237.50
  • 52 Week Low: 103.00
  • Currency: UK Pounds
  • Shares Issued: 240.19m
  • Volume: 1,359,855
  • Market Cap: £279.10m
  • Beta: 0.12

PureTech Health's Vor wins FDA fast-track approval for cancer drug

By Frank Prenesti

Date: Friday 10 Sep 2021

LONDON (ShareCast) - (Sharecast News) - Clinical stage biotherapeutics firm PureTech Health on Friday said its founded entity, Vor Biopharma, had won US fast track approval for its leukaemia treatment.
The US Food and Drug Administration granted the designation to VOR33, a hematopoietic stem cell therapeutic candidate for the treatment of acute myeloid leukaemia.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

PRTC Market Data

Currency UK Pounds
Share Price 116.20p
Change Today 13.20p
% Change 12.82 %
52 Week High 237.50
52 Week Low 103.00
Volume 1,359,855
Shares Issued 240.19m
Market Cap £279.10m
Beta 0.12

PRTC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.65% above the market average29.65% above the market average29.65% above the market average29.65% above the market average29.65% above the market average
82.98% above the sector average82.98% above the sector average82.98% above the sector average82.98% above the sector average82.98% above the sector average
Price Trend
72.65% below the market average72.65% below the market average72.65% below the market average72.65% below the market average72.65% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Income Not Available
Growth
65.44% below the market average65.44% below the market average65.44% below the market average65.44% below the market average65.44% below the market average
80.65% below the sector average80.65% below the sector average80.65% below the sector average80.65% below the sector average80.65% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

PRTC Dividends

No dividends found

Trades for 11-Apr-2025

Time Volume / Share Price
16:09 551 @ 116.20p
16:09 662 @ 116.40p
16:09 1,335 @ 116.40p
16:09 996 @ 116.40p
16:09 904 @ 116.40p

PRTC Key Personnel

Chair Raju Kucherlapati
CEO Bharatt Chowrira

Top of Page